| 摘要 |
A process for inhibiting platelet aggregation or thrombus formation by the addition of a member selected from the group consisting of a compound of the formula: <IMAGE> WHEREIN X is an alkyl or alkenyl chain having 2-8 carbon atoms, one of which carbon atoms may be in the form of a carbonyl group, Y is H, alkyl, dialkylaminoethyl, aryl, aralkyl or aryl and aralkyl substituted with one or more R, and R is H, lower alkyl, lower alkoxy, halogen, CF3, NO2, OH, CN, COOR1, <IMAGE> NHCOR1, NR1R2 or <IMAGE> where R1 and R2 are each selected from the group consisting of H and lower alkyl; R, R1 and R2 being the same or different and n is 0-5; and pharmaceutically acceptable salts thereof, to in vivo and in vitro platelet systems.
|
